CVE-2024-2275: Bdtask G-Prescription Gynaecology & OBS Consultation Software OBS Patient/Gynee Prescription cross site scripting
Bdtask · G-Prescription Gynaecology & OBS Consultation Software
Affected: Bdtask G-Prescription Gynaecology & OBS Consultation Software · Exploitation: unlikely (under 1%)
Not in CyberSIXT coverage yet: no article names this CVE. This page shows the public record.
Higher than 39% of scored CVEs
DescriptionCVE.org
A vulnerability, which was classified as problematic, was found in Bdtask G-Prescription Gynaecology & OBS Consultation Software 1.0. Affected is an unknown function of the component OBS Patient/Gynee Prescription. The manipulation of the argument Patient Title/Full Name/Address/Cheif Complain/LMP/Menstrual Edd/OBS P/OBS Alc/Medicine Name/Medicine Type/Ml/Dose/Days/Comments/Template Name leads to cross site scripting. It is possible to launch the attack remotely. The exploit has been disclosed to the public and may be used. The identifier of this vulnerability is VDB-256044. NOTE: The vendor was contacted early about this disclosure but did not respond in any way.
Affected products1
From the CVE record. A product or version that is not listed is unknown, not unaffected.
- Bdtask · G-Prescription Gynaecology & OBS Consultation Software1.0
On the Atlas
Every published CVE is on the CyberSIXT Atlas, grouped by weakness, vendor and month.
- Exploitation
- Unlikely (under 1%). EPSS under 1%, or no score yet.
- CISA KEV
- Not listed
- Public check
- No public nuclei template
- Weakness
- Cross-site Scripting
- Vendor
- Bdtask
- Published
- March 2024
CoverageNo articles yet
No CyberSIXT article names CVE-2024-2275 yet, so there is no coverage timeline, action brief or change log for it. Everything on this page comes from the public CVE record, CISA KEV, EPSS and the nuclei template index. Search the archive or see the CVEs in the news.